Institutional Inflows Drive 14.81% Weekly Gain in NEAR Amid Market Caution

NEAR Protocol and Injective (INJ) have shown unexpected strength in a cautiously positioned market, with institutional inflows playing a critical role in their recent recovery. NEAR’s price has risen 14.81% in a week and 11.78% in a month, despite a 16.37% decline over six months. Current price activity is confined between $2 and $3, with resistance at $3.63 and support at $1.47. The RSI stands at 57.21, and the Momentum Indicator is at 0.383, suggesting moderate bullish momentum without extreme overbought conditions. Institutional investors have been particularly active in NEAR, drawn to its Layer-1 blockchain infrastructure and ecosystem expansion, including partnerships with Aurora Labs and Subzero Labs [1].

Injective has also seen a 16% weekly price increase, contributing to a 20% rise over one month, while showing a marginal decline of 1% over six months. The coin's price currently oscillates between $10 and $16, with key support at $7 and resistance at $19. Technical indicators, such as a nearly neutral oscillator and a moderate RSI, suggest that the market remains in a consolidation phase. However, the recent bullish activity points to growing institutional interest, particularly from funds looking to capitalize on high-potential blockchain projects [1].

The recent performance of NEAR and INJ is largely attributed to a surge in institutional capital. NEAR’s price breakout above $2.495 marked a turning point in its trajectory, supported by a bullish MACD crossover and a growing ecosystem. This trend underscores a broader shift in investor sentiment, with large investors increasingly allocating funds to altcoins with strong fundamentals and growth potential. NEAR’s adoption of innovative features like “transaction intents” has further enhanced its appeal, simplifying smart contract interactions and broadening its user base [1].

Both NEAR and INJ are benefiting from increased liquidity and strategic developments. NEAR’s recent cross-chain integrations with Cardano represent a significant expansion in its reach, while Injective’s price volatility reflects its dynamic market positioning. Analysts suggest that NEAR’s price could trade between $2.80 and $3.17 in August, with a potential target of $4.66 by year-end if the current momentum is maintained [1]. These projections highlight the growing confidence among investors in the long-term viability of these projects.

The institutional focus on NEAR and INJ reflects broader market expectations for increased liquidity in Q4 2025. Projects with strong narratives and technical foundations, such as NEAR, are particularly well-positioned to attract capital as the market prepares for a potential bull cycle. NEAR’s Layer-1 infrastructure and Injective’s speculative appeal represent distinct yet complementary opportunities for traders and long-term investors [1].

Source: [1] NEAR Defies Market Caution — How Institutional Flows Are Fueling A Surprise Recovery (https://en.bitcoinsistemi.com/near-defies-market-caution-how-institutional-flows-are-fueling-a-surprise-recovery/)